机构地区:[1]首都医科大学附属北京同仁医院老年医学科/干部医疗科,100730 [2]首都医科大学附属北京同仁医院内分泌科,100730
出 处:《中华全科医师杂志》2018年第7期533-537,共5页Chinese Journal of General Practitioners
摘 要:目的了解糖尿病视网膜病变(DR)及不同严重程度的DR与动脉粥样硬化性心血管疾病(ASCVD)的相关性。方法从2010年7月至2011年3月在北京市昌平区慢性疾病和危险因素的健康调查对象中,筛选出符合入选、排除标准的2型糖尿病患者654例,其中有ASCVD者73例(ASCVD组),无ASCVD者581例(非-ASCVD组),进行病例对照研究。结果ASCVD组患者年龄[58.5(53.9,65.9)岁]、服糖后2 h血糖[16.26(11.08,19.20) mmol/L]、糖化血红蛋白[7.20%(6.55%,8.85%)]、收缩压[151 (133,165) mmHg(1 mmHg=0.133 kPa)]和ASCVD家族史[45例(61.6%)]、女性比例[52例(71.2%)]明显高于非-ASCVD组患者[52.4(46.5,58.3)岁,13.10(8.99,17.93) mmol/L,6.70%(6.00%, 7.90%),143 (131,158) mmHg,256例(44.1%)和307例(52.8%)],而估算的肾小球滤过率(eGFR)明显低于非-ASCVD组[87.2(75.0,103.0)与94.6(84.8,106.3) ml·min^-1·1.73 m^-2],差异均有统计学意义(Z=-5.86,P=0.00;Z=-2.35,P=0.02;Z=-3.33,P=0.00;Z=-2.28,P=0.02;χ^2=8.07,P=0.01;χ^2=-8.86,P=0.00;Z=-3.47,P=0.00)。ASCVD患者中罹患DR的比例明显高于非-ASCVD组[19.2%(14/74)与8.3%(48/581),Pearson χ^2=9.01, P=0.00]。logistic回归分析显示,DR与ASCVD呈正相关[OR(95%CI):2.64(1.37~5.06),P=0.00];进一步将DR按病变程度分为非增殖期DR(NPDR)和增殖期DR(PDR),只有PDR是ASCVD的相关因素[OR(95%CI):12.05(2.63~55.12),P=0.00]。在校正年龄、性别、ASCVD家族史等传统ASCVD危险因素后,PDR仍与ASCVD相关,PDR患者的ASCVD患病风险增加718%[OR(95% CI):8.18(1.56~42.81),P=0.01]。结论2型糖尿病患者DR与ASCVD密切相关,随着DR病变严重程度的增加,ASCVD的患病风险亦随之增加。调整传统危险因素后,PDR与ASCVD患病风险的增加存在独立正相关�ObjectiveTo investigate the association between diabetic retinopathy (DR) and atherosclerosis cardiovascular disease (ASCVD).MethodsClinical data of 654 patients with type 2 diabetic mellitus (T2DM) were collected from a cross sectional, population based survey on chronic diseases and risk factors which was conducted in Beijing Changping district from July 2010 to March 2011. Among 654 T2DM patients, there were 73 patients with ASCVD (ASCVD group) and 581 patients without ASCVD (non-ASCVD group). The association between DR and ASCVD was analyzed.ResultsPatients with ASCVD had significantly older age[58.5(53.9, 65.9) years], more female sex[52(71.2%)], higher proportion of ASCVD history [45(61.6%)], higher levels of PG 2 h[16.26(11.08, 19.20) mmol/L], HbA1c[7.20(6.55, 8.85)%], systolic pressure [151(133, 165) mmHg(1 mmHg=0.133 kPa)] and lower eGFR[87.2(75.0, 103.0) ml·min-1·1.73 m-2] than non-ASCVD patients[52.4(46.5, 58.3) years, Z=-5.86, P=0.00; 307(52.8%), χ2=-8.86, P=0.00; 256(44.1%), χ2=8.07, P=0.01; 13.10(8.99, 17.93) mmol/L, Z=-2.35, P=0.02; 6.70(6.00, 7.90)%, Z=-3.33, P=0.00; 143(131, 158) mmHg, χ2=-2.28, P=0.02; 94.6(84.8, 106.3) ml·min-1·1.73 m-2,Z=- 3.47, P=0.00]. The trend to develop DR in ASCVD group was significantly higher than that in non-ASCVD group [19.2%(14/74) vs. 8.3%(48/581), χ2=9.01, P=0.00]. DR was an independent statistical indicator of the presence of ASCVD [OR(95%CI): 2.64 (1.37-5.06), P=0.00]. Furthermore, when DR was divided into NPDR and PDR according to its severity, only PDR was significantly associated with incident ASCVD [OR(95%CI): 12.05 (2.63-55.12), P=0.00]. After adjusting for traditional ASCVD risk factors, such an association still existed, with the risk of having ASCVD increasing by 718% [OR (95% CI): 8.18(1.56-42.81), P=0.01]. DR associates strongly with ASCVD in the Chinese population with T2DM.ConclussionWith the severity of DR increasing, the ris
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...